688067.SH
爱威科技
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 22.55
−1.44%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 219.4M | 219.7M | 203.3M | 200.3M | 196.8M |
| Cost of Revenue | 85.6M | 86.9M | 82.3M | 87.8M | 90.8M |
| Gross Profit | 133.9M | 132.8M | 121.0M | 112.6M | 106.0M |
| Operating Expenses | |||||
| R&D Expense | 27.1M | 27.3M | 25.4M | 27.7M | 33.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 21.4M | 20.8M | 18.3M | 16.3M | 15.5M |
| Selling & Marketing Expense | 62.2M | 63.1M | 64.4M | 58.1M | 54.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 115.2M | 115.3M | 111.4M | 105.7M | 106.1M |
| Cost and Expenses | 200.7M | 202.2M | 193.7M | 193.5M | 196.9M |
| Operating Income (EBIT) | 31.7M | 30.0M | 23.6M | 22.4M | 18.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 31.6M | 29.9M | 23.5M | 22.4M | 18.2M |
| Income Tax Expense | 1.7M | 1.1M | 689.9K | 825.0K | 225.4K |
| Bottom Line | |||||
| Net Income | 30.0M | 28.9M | 22.8M | 21.5M | 18.0M |
| Earnings from Cont. Ops | 30.0M | 28.9M | 22.8M | 21.5M | 18.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 30.0M | 28.9M | 22.8M | 21.5M | 18.0M |
| Per Share | |||||
| Basic EPS | CN¥0.44 | CN¥0.43 | CN¥0.34 | CN¥0.32 | CN¥0.26 |
| Diluted EPS | CN¥0.44 | CN¥0.43 | CN¥0.34 | CN¥0.32 | CN¥0.26 |
| Revenue Per Share | CN¥3.25 | CN¥3.27 | CN¥3.03 | CN¥2.98 | CN¥2.85 |
| Shares | |||||
| Basic Shares Outstanding | 67.5M | 67.1M | 67.2M | 67.3M | 69.1M |
| Diluted Shares Outstanding | 67.5M | 67.1M | 67.2M | 67.3M | 69.1M |
| Profitability Metrics | |||||
| EBITDA | — | 42.3M | 36.0M | 33.9M | 28.2M |
| D&A | — | 12.3M | 12.4M | 11.5M | 9.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026